Corvus Pharmaceuticals (CRVS) Stock
Corvus Pharmaceuticals (CRVS) closed at $10.17 on Nov 17, 2026; its Tenet Score is 52 of 100 against 340 Healthcare peers.
34 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $10.17
- Nov 17, 2026
- Market cap
- $894.1M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 6.39 – 26.95
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 52/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Corvus Pharmaceuticals Inc scores 52/100. Mixed. Strongest on financial health, quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 52 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
13F flows & insider trades land here.
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Savara IncSVRA | 32 | $985.1M |
| Verastem IncVSTM | 17 | $970.3M |
| Pharming Group N.V.PHAR | 40 | $883.4M |
| MeiraGTx Holdings plcMGTX | 69 | $854.2M |
| Syndax Pharmaceuticals IncSNDX | 49 | $815.3M |
| Collegium Pharmaceutical IncCOLL | 60 | $790.2M |
| Monte Rosa Therapeutics IncGLUE | 66 | $782.7M |
| Lexicon Pharmaceuticals IncLXRX | 41 | $779.2M |
| Ardelyx IncARDX | 46 | $771.7M |
| Annexon IncANNX | 37 | $733.7M |
Common questions
What sector and industry is Corvus Pharmaceuticals in?
Corvus Pharmaceuticals is in the Healthcare sector and the Drugs industry.
What is Corvus Pharmaceuticals' Tenet Score?
Corvus Pharmaceuticals' Tenet Score is 52 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




